Moreover, pharmacological PKR inhibition can reduce IL‐1β levels in a rat model of excitotoxicity and neuroinflammation (Tronel, Page, Bodard, Chalon, & Antier, 2014), but our results show for the first time that PKR genetic blockade reduces neuroinflammation in an AD transgenic mice model. This evidence concerns the gene IL1B and Alzheimer disease.